Back to top
more

Stryker (SYK)

(Delayed Data from NYSE)

$376.37 USD

376.37
1,192,082

+1.43 (0.38%)

Updated Aug 7, 2025 04:00 PM ET

After-Market: $376.43 +0.06 (0.02%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth A Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 37% (156 out of 246)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

HLN or SYK: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

HLN vs. SYK: Which Stock Is the Better Value Option?

Zacks Equity Research

Why Is Stryker (SYK) Down 7.6% Since Last Earnings Report?

by Zacks Equity Research

Stryker (SYK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Stryker's (SYK) Q Guidance Successful in First Surgery

by Zacks Equity Research

Stryker (SYK) successfully completes first surgical case using its Q Guidance system with Cranial Guidance software. An Early Product Surveillance is underway for the combined technology.

Zacks Equity Research

The Zacks Analyst Blog Highlights Apple, Chevron, Accenture, Broadcom and Stryker

by Zacks Equity Research

Apple, Chevron, Accenture, Broadcom and Stryker are included in this Analyst Blog.

Mark Vickery headshot

Top Analyst Reports for Apple, Chevron & Accenture

by Mark Vickery

Today's Research Daily features new research reports on 16 major stocks, including Apple Inc. (AAPL), Chevron Corporation (CVX) and Accenture plc (ACN).

Zacks Equity Research

Here's Why You Should Retain Stryker (SYK) Stock for Now

by Zacks Equity Research

Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio. However, pricing pressure weighs on the stock.

Andrew Rocco headshot

3 Healthcare Trends to Ride for Longevity

by Andrew Rocco

Because of their longevity, predictability, and stability, healthcare trends can persist for years. The companies covered today are fundamentally and technically robust stocks currently taking advantage of these trends.

Zacks Equity Research

HLN or SYK: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

HLN vs. SYK: Which Stock Is the Better Value Option?

Zacks Equity Research

Zacks Industry Outlook Highlights Stryker, Boston Scientific, Zimmer Biomet and Insulet

by Zacks Equity Research

Stryker, Boston Scientific, Zimmer Biomet and Insulet are part of the Zacks Industry Outlook article.

Indrajit Bandyopadhyay headshot

4 Medical Products Stocks to Capitalize on the Industry's Recovery

by Indrajit Bandyopadhyay

Despite the ongoing macro headwinds, recovering demand for medical procedures and cost-cutting initiatives should lend support to the Zacks Medical-Products industry. SYK, BSX, ZBH and PODD are well-poised to gain from the favorable factors.

Zacks Equity Research

BAX vs. SYK: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

BAX vs. SYK: Which Stock Is the Better Value Option?

Zacks Equity Research

Stryker (SYK) Q1 Earnings Beat Estimates, Volume Improves

by Zacks Equity Research

Stryker's (SYK) first-quarter earnings reflect strong performance across its segments. However, unfavorable currency movement hurts sales growth and rising costs affect margins.

Zacks Equity Research

Stryker (SYK) Tops Q1 Earnings and Revenue Estimates

by Zacks Equity Research

Stryker (SYK) delivered earnings and revenue surprises of 7% and 4.91%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Andrew Rocco headshot

Healthcare: An Essential Sector (3 Stocks to Buy Ahead of Earnings)

by Andrew Rocco

Healthcare stocks are an excellent place to park your money in the current market environment. Due to it's necessity, the sector tends to due well in any economy.

Zacks Equity Research

Stryker (SYK) to Report Q1 Earnings: What's in the Cards?

by Zacks Equity Research

Stryker's (SYK) first-quarter results are expected to reflect strong segmental performances. However, rising costs are likely to have continued hurting margins.

Zacks Equity Research

Here's How Much a $1000 Investment in Stryker Made 10 Years Ago Would Be Worth Today

by Zacks Equity Research

Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.

Zacks Equity Research

HAE vs. SYK: Which Stock Is the Better Value Option?

by Zacks Equity Research

HAE vs. SYK: Which Stock Is the Better Value Option?

Zacks Equity Research

Encompass Health (EHC) Up 32% in 6 Months: More Room to Run?

by Zacks Equity Research

Encompass Health (EHC) is well-poised for growth on the back of growing facility count within its Inpatient Rehabilitation segment and sound liquidity position.

Zacks Equity Research

Stryker (SYK) is a Great Momentum Stock: Should You Buy?

by Zacks Equity Research

Does Stryker (SYK) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks Equity Research

Here's Why You Should Add Stryker (SYK) Stock to Your Portfolio

by Zacks Equity Research

Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio. However, pricing pressure weighs on the company.

Zacks Equity Research

Here's How Much You'd Have If You Invested $1000 in Stryker a Decade Ago

by Zacks Equity Research

Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.

Zacks Equity Research

MedTech Bigwigs in Spotlight as AI Revolutionizes Healthcare

by Zacks Equity Research

MedTech player like Medtronic (MDT) are integrating artificial intelligence (AI) capabilities to aid therapeutic and diagnostic applications.

Zacks Equity Research

HAE vs. SYK: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

HAE vs. SYK: Which Stock Is the Better Value Option?

Zacks Equity Research

ESLOY vs. SYK: Which Stock Is the Better Value Option?

by Zacks Equity Research

ESLOY vs. SYK: Which Stock Is the Better Value Option?

Derek Lewis headshot

Navigating Volatility: 3 Stocks Worthy of Consideration

by Derek Lewis

Powell believes returning to bigger rate hikes could be necessary if data suggests the U.S. economy is heating up again. Is this the correct path to take?